Neuphoria Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -97.1% | -97.1% | -74.9% |
| FY2024 | -88.6% | -88.6% | -56.0% |
| FY2025 | -1.9% | -1.9% | -1.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -97.1% | -97.1% | -74.9% |
| FY2024 | -88.6% | -88.6% | -56.0% |
| FY2025 | -1.9% | -1.9% | -1.3% |